Results 71 to 80 of about 4,563 (204)
Microbiome‐Endocannabinoidome Crosstalk as an Immunometabolic Rheostat in Inflammatory Disease
The microbiome‐eCBome axis is operationalized across five measurable domains: microbial functions, compartment‐specific lipid signaling, barrier/translocation, immune‐cell programming, and tissue outcomes. Engineered PEA‐ and OEA‐producing bacteria provide causal proof‐of‐concept, while translation requires tissue‐resolved lipidomics, validated barrier
Reuben S. Maghembe +3 more
wiley +1 more source
Aims: Endocannabinoids are lipid mediators involved in the regulation of glucose homeostasis. They interact with the canonical cannabinoid receptors CB1 and CB2, and it is now apparent that some cannabinoid receptor ligands are also agonists at GPR55 ...
Shanta J Persaud (9985865) +6 more
core +4 more sources
Cannabinoids act as pleiotropic compounds exerting, among others, a broad-spectrum of neuroprotective effects. These effects have been investigated in the last years in different preclinical models of neurodegeneration, with the cannabinoid type-1 (CB1 ...
Sonia Burgaz +13 more
doaj +1 more source
Cannabidiol in Adults With Lennox–Gastaut Syndrome: Real‐World Experience
Cannabidiol showed sustained effectiveness and good tolerability in adults with LGS, with high retention over a median follow‐up of 41 months. Treatment was associated with improvement in seizure burden, increased seizure‐free days, fewer seizure‐related hospital admissions, and caregiver‐reported improvement in cognitive and behavioural functioning ...
Pyae Aung +9 more
wiley +1 more source
The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55
Lysophosphatidylinositol (LPI) is a subspecies of lysophospholipid and is assumed to be not only a degradation product of phosphatidylinositol (PI), but also a bioactive lysophospholipid mediator. However, not much attention has been directed toward LPI compared to lysophosphatidic acid (LPA), since the receptor for LPI has not been identified.
Atsushi, Yamashita +5 more
openaire +2 more sources
Docking studies of identified GPR55 ligands using a GPR55 inactive state model allow rationalizing key structural features involved in ligand–receptor binding.
Paula Morales +6 more
doaj +1 more source
Metabolite Signatures in Postpartum Prediabetes and Diabetes Among Indian Women With Prior Gestational Diabetes Mellitus: Insights From CHIP‐F Study. ABSTRACT Aims Gestational diabetes mellitus (GDM) increases the risk of postpartum dysglycaemia. This study investigates candidate metabolites and perturbed metabolic pathways associated with postpartum ...
Sahil Kapoor +8 more
wiley +1 more source
GPR55 as a novel target in disease control of multiple sclerosis [PDF]
PhDMultiple sclerosis (MS) is a neurodegenerative disease associated with immune attack of the central nervous system (CNS) leading to neuronal and axonal loss.
Sisay, Sofia
core +1 more source
Off-Target Cannabinoid Effects Mediated by GPR55 [PDF]
Given the vast therapeutic potential of the endocannabinoid system, the revelation of a novel cannabinoid-sensitive target was treated with great excitement. The orphan G-protein coupled receptor 55 (GPR55) was initially touted as a novel cannabinoid target in early industrial patent literature.
openaire +3 more sources
ABSTRACT The scope, organization, and biological significance of innate immune functions across structural cell types remain poorly defined. To address these fundamental knowledge gaps, we analyzed experimental data of transcriptomes generated by our group and others.
Juanjuan Liu +22 more
wiley +1 more source

